

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.96376721 |
| 2 | negative T cell selection (GO:0043383) | 7.17842057 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.02992141 |
| 4 | negative regulation of cell killing (GO:0031342) | 6.89388886 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.89388886 |
| 6 | positive thymic T cell selection (GO:0045059) | 6.79906198 |
| 7 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.76143635 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.76143635 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.60889934 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.47813548 |
| 11 | response to interleukin-15 (GO:0070672) | 6.40253625 |
| 12 | interferon-gamma production (GO:0032609) | 6.28312708 |
| 13 | positive T cell selection (GO:0043368) | 6.22504304 |
| 14 | cellular response to interleukin-15 (GO:0071350) | 6.15737276 |
| 15 | thymic T cell selection (GO:0045061) | 6.08629743 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 6.04865214 |
| 17 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.86663004 |
| 18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.83672646 |
| 19 | T cell selection (GO:0045058) | 5.83240970 |
| 20 | T cell migration (GO:0072678) | 5.35995657 |
| 21 | regulation of T cell tolerance induction (GO:0002664) | 5.16190318 |
| 22 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 5.15695262 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.10363924 |
| 24 | regulation of regulatory T cell differentiation (GO:0045589) | 4.96722146 |
| 25 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.89824080 |
| 26 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.89824080 |
| 27 | modulation by symbiont of host immune response (GO:0052553) | 4.89824080 |
| 28 | positive regulation by symbiont of host defense response (GO:0052509) | 4.89824080 |
| 29 | modulation by symbiont of host defense response (GO:0052031) | 4.89824080 |
| 30 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.89824080 |
| 31 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.66076278 |
| 32 | detection of other organism (GO:0098543) | 4.63370493 |
| 33 | T cell receptor signaling pathway (GO:0050852) | 4.58094831 |
| 34 | leukocyte aggregation (GO:0070486) | 4.46499031 |
| 35 | T cell costimulation (GO:0031295) | 4.46420350 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 4.42665662 |
| 37 | lymphocyte costimulation (GO:0031294) | 4.40331378 |
| 38 | detection of bacterium (GO:0016045) | 4.37216933 |
| 39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.36839727 |
| 40 | B cell receptor signaling pathway (GO:0050853) | 4.35370043 |
| 41 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.34480347 |
| 42 | macrophage activation involved in immune response (GO:0002281) | 4.34121431 |
| 43 | positive regulation of tolerance induction (GO:0002645) | 4.30867182 |
| 44 | tolerance induction (GO:0002507) | 4.27181628 |
| 45 | neutrophil activation involved in immune response (GO:0002283) | 4.21056360 |
| 46 | regulation of B cell differentiation (GO:0045577) | 4.20651463 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 4.19495937 |
| 48 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.13116741 |
| 49 | positive regulation of interleukin-2 production (GO:0032743) | 4.12775179 |
| 50 | activated T cell proliferation (GO:0050798) | 4.03247854 |
| 51 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.02372720 |
| 52 | positive regulation of isotype switching (GO:0045830) | 3.95418157 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.94786426 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.92332701 |
| 55 | regulation of tolerance induction (GO:0002643) | 3.87500423 |
| 56 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.86492174 |
| 57 | cellular extravasation (GO:0045123) | 3.84486118 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 3.81581755 |
| 59 | immunoglobulin mediated immune response (GO:0016064) | 3.80359753 |
| 60 | regulation of isotype switching (GO:0045191) | 3.79978990 |
| 61 | positive regulation of humoral immune response (GO:0002922) | 3.77592490 |
| 62 | response to peptidoglycan (GO:0032494) | 3.75145887 |
| 63 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.68362536 |
| 64 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.66986386 |
| 65 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.63190164 |
| 66 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.62565344 |
| 67 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.60709079 |
| 68 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.60709079 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.60114620 |
| 70 | microglial cell activation (GO:0001774) | 3.58611678 |
| 71 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.57950647 |
| 72 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.54311757 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.51784926 |
| 74 | type I interferon signaling pathway (GO:0060337) | 3.51784926 |
| 75 | positive regulation of DNA recombination (GO:0045911) | 3.50720362 |
| 76 | T cell homeostasis (GO:0043029) | 3.50634562 |
| 77 | macrophage activation (GO:0042116) | 3.48501027 |
| 78 | alpha-beta T cell activation (GO:0046631) | 3.48039716 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.47445812 |
| 80 | NIK/NF-kappaB signaling (GO:0038061) | 3.42531247 |
| 81 | detection of biotic stimulus (GO:0009595) | 3.41022645 |
| 82 | positive regulation of B cell differentiation (GO:0045579) | 3.40487829 |
| 83 | positive regulation of immunoglobulin production (GO:0002639) | 3.40272482 |
| 84 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.39021441 |
| 85 | response to host immune response (GO:0052572) | 3.39021441 |
| 86 | positive regulation of B cell mediated immunity (GO:0002714) | 3.36369646 |
| 87 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.36369646 |
| 88 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.35984352 |
| 89 | regulation of response to interferon-gamma (GO:0060330) | 3.34405404 |
| 90 | alpha-beta T cell differentiation (GO:0046632) | 3.34166377 |
| 91 | leukocyte cell-cell adhesion (GO:0007159) | 3.33562986 |
| 92 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.32915711 |
| 93 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.32915711 |
| 94 | regulation of B cell mediated immunity (GO:0002712) | 3.32766401 |
| 95 | natural killer cell activation (GO:0030101) | 3.31055736 |
| 96 | respiratory burst (GO:0045730) | 3.30555658 |
| 97 | T cell differentiation (GO:0030217) | 3.30545912 |
| 98 | B cell proliferation (GO:0042100) | 3.28740129 |
| 99 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.27660523 |
| 100 | regulation of immunoglobulin production (GO:0002637) | 3.27353763 |
| 101 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.27224076 |
| 102 | neutrophil activation (GO:0042119) | 3.26126288 |
| 103 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.22486335 |
| 104 | lymphocyte homeostasis (GO:0002260) | 3.22377522 |
| 105 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.21165716 |
| 106 | myeloid cell activation involved in immune response (GO:0002275) | 3.17970504 |
| 107 | mature B cell differentiation (GO:0002335) | 3.17950854 |
| 108 | response to host (GO:0075136) | 3.16738743 |
| 109 | response to host defenses (GO:0052200) | 3.16738743 |
| 110 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16738743 |
| 111 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.15999803 |
| 112 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.14548025 |
| 113 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.14166885 |
| 114 | regulation of interleukin-2 production (GO:0032663) | 3.13556185 |
| 115 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.11408026 |
| 116 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09998802 |
| 117 | mast cell activation (GO:0045576) | 3.09891477 |
| 118 | regulation of B cell proliferation (GO:0030888) | 3.06604150 |
| 119 | T cell proliferation (GO:0042098) | 3.05444383 |
| 120 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.05157355 |
| 121 | positive regulation of B cell proliferation (GO:0030890) | 3.04062909 |
| 122 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.03924493 |
| 123 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.02577146 |
| 124 | heterotypic cell-cell adhesion (GO:0034113) | 3.02272399 |
| 125 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.01865759 |
| 126 | lymph node development (GO:0048535) | 3.00666862 |
| 127 | regulation of alpha-beta T cell activation (GO:0046634) | 3.00500349 |
| 128 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.99746407 |
| 129 | granulocyte activation (GO:0036230) | 2.98247748 |
| 130 | cellular response to zinc ion (GO:0071294) | 2.97084355 |
| 131 | positive regulation of granulocyte differentiation (GO:0030854) | 2.96993773 |
| 132 | response to type I interferon (GO:0034340) | 2.96806947 |
| 133 | T-helper cell differentiation (GO:0042093) | 2.96673916 |
| 134 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.96673916 |
| 135 | B cell mediated immunity (GO:0019724) | 2.95904362 |
| 136 | response to muramyl dipeptide (GO:0032495) | 2.94061998 |
| 137 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.93039557 |
| 138 | regulation of cell killing (GO:0031341) | 2.92247165 |
| 139 | negative regulation of innate immune response (GO:0045824) | 2.90642839 |
| 140 | regulation of mast cell degranulation (GO:0043304) | 2.90476157 |
| 141 | T cell activation (GO:0042110) | 2.90391466 |
| 142 | positive regulation of B cell activation (GO:0050871) | 2.89792504 |
| 143 | lymphocyte migration (GO:0072676) | 2.88287700 |
| 144 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.87946496 |
| 145 | positive regulation of T cell activation (GO:0050870) | 2.84593336 |
| 146 | myeloid dendritic cell activation (GO:0001773) | 2.84419489 |
| 147 | dendritic cell chemotaxis (GO:0002407) | 2.82930152 |
| 148 | neutrophil mediated immunity (GO:0002446) | 2.82560546 |
| 149 | positive regulation of mast cell activation (GO:0033005) | 2.82182632 |
| 150 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.81341170 |
| 151 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.81196224 |
| 152 | dendritic cell migration (GO:0036336) | 2.81032308 |
| 153 | negative regulation of type 2 immune response (GO:0002829) | 2.76526337 |
| 154 | germinal center formation (GO:0002467) | 2.76237896 |
| 155 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75031455 |
| 156 | regulation of antigen processing and presentation (GO:0002577) | 2.72846049 |
| 157 | myeloid leukocyte activation (GO:0002274) | 2.72009014 |
| 158 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.70176010 |
| 159 | defense response to protozoan (GO:0042832) | 2.68651276 |
| 160 | positive regulation of interferon-alpha production (GO:0032727) | 2.67985419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 8.27878286 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.44351281 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.17803495 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.24687040 |
| 5 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.16599111 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.94638987 |
| 7 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.89790577 |
| 8 | MYC_22102868_ChIP-Seq_BL_Human | 3.64417215 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.62957338 |
| 10 | MYB_26560356_Chip-Seq_TH2_Human | 3.31222202 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.30700219 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.24484962 |
| 13 | MYB_26560356_Chip-Seq_TH1_Human | 2.93815903 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.93326458 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.86904933 |
| 16 | UTX_26944678_Chip-Seq_JUKART_Human | 2.64560465 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.56421225 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.51323046 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45204358 |
| 20 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.34309152 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.33055821 |
| 22 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27738060 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.23777618 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22547912 |
| 25 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.19371675 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15987377 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.09699094 |
| 28 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.09333164 |
| 29 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.08077149 |
| 30 | MAF_26560356_Chip-Seq_TH2_Human | 2.01726916 |
| 31 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.01570085 |
| 32 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.93587410 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88250844 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.84772506 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.82210424 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.80195597 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.77667864 |
| 38 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.77445952 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.74094466 |
| 40 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.72924317 |
| 41 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70085087 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.65125208 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63554528 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.62597582 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.60752324 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.55422693 |
| 47 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.55205553 |
| 48 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.54275806 |
| 49 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50047860 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49333134 |
| 51 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47832317 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42411397 |
| 53 | GATA3_26560356_Chip-Seq_TH2_Human | 1.36664832 |
| 54 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.35225587 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33876392 |
| 56 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.33476179 |
| 57 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32376392 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31422803 |
| 59 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25238747 |
| 60 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21421983 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17371921 |
| 62 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16078208 |
| 63 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15584534 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.12228283 |
| 65 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11586574 |
| 66 | GATA1_22025678_ChIP-Seq_K562_Human | 1.10704270 |
| 67 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10640181 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08977059 |
| 69 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06873290 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05728829 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04711582 |
| 72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.01064030 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.99854520 |
| 74 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99627814 |
| 75 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97936577 |
| 76 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.97915008 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96957880 |
| 78 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95153960 |
| 79 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94339346 |
| 80 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.94142591 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93506034 |
| 82 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93185420 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92403259 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91551411 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91095735 |
| 86 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90853347 |
| 87 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89333016 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.88512952 |
| 89 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86708536 |
| 90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.83313715 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82412397 |
| 92 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81342861 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.80413136 |
| 94 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.79213661 |
| 95 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.77785689 |
| 96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77677535 |
| 97 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76452881 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.76059186 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75419089 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.71604420 |
| 101 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71276271 |
| 102 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71119697 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.70254163 |
| 104 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69796736 |
| 105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.69572027 |
| 106 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.69572027 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69429170 |
| 108 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68473140 |
| 109 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.65963971 |
| 110 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.65869870 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.65311562 |
| 112 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.61828095 |
| 113 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.60046022 |
| 114 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.59471845 |
| 115 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.58428081 |
| 116 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.57588542 |
| 117 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.57151529 |
| 118 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.56479382 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 4.93782855 |
| 2 | MP0005671_abnormal_response_to | 4.46720306 |
| 3 | MP0001835_abnormal_antigen_presentation | 4.01566532 |
| 4 | MP0001800_abnormal_humoral_immune | 3.73812522 |
| 5 | MP0005387_immune_system_phenotype | 3.62110237 |
| 6 | MP0001790_abnormal_immune_system | 3.62110237 |
| 7 | MP0000685_abnormal_immune_system | 3.56100202 |
| 8 | MP0001873_stomach_inflammation | 2.99126554 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.97110387 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.94546077 |
| 11 | MP0002723_abnormal_immune_serum | 2.92930866 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.89803732 |
| 13 | MP0001819_abnormal_immune_cell | 2.88843957 |
| 14 | MP0002398_abnormal_bone_marrow | 2.80825002 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.66828024 |
| 16 | MP0000716_abnormal_immune_system | 2.50068508 |
| 17 | MP0009785_altered_susceptibility_to | 2.46283324 |
| 18 | MP0005025_abnormal_response_to | 2.38244000 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.34804153 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.34548808 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.34165866 |
| 22 | MP0000689_abnormal_spleen_morphology | 2.30573834 |
| 23 | MP0000703_abnormal_thymus_morphology | 2.29721422 |
| 24 | MP0002405_respiratory_system_inflammati | 2.22929019 |
| 25 | MP0002722_abnormal_immune_system | 2.22627235 |
| 26 | MP0010155_abnormal_intestine_physiology | 2.17646131 |
| 27 | MP0002006_tumorigenesis | 2.17313642 |
| 28 | MP0006082_CNS_inflammation | 2.15808143 |
| 29 | MP0003724_increased_susceptibility_to | 2.13785484 |
| 30 | MP0003866_abnormal_defecation | 2.11441473 |
| 31 | MP0003436_decreased_susceptibility_to | 2.09862015 |
| 32 | MP0003303_peritoneal_inflammation | 2.03383167 |
| 33 | MP0002429_abnormal_blood_cell | 2.03208253 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.98521832 |
| 35 | MP0002419_abnormal_innate_immunity | 1.86713813 |
| 36 | MP0004947_skin_inflammation | 1.81220051 |
| 37 | MP0004808_abnormal_hematopoietic_stem | 1.81037177 |
| 38 | MP0008260_abnormal_autophagy | 1.75877658 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.73273193 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.72370434 |
| 41 | MP0004510_myositis | 1.63315770 |
| 42 | MP0001853_heart_inflammation | 1.58053565 |
| 43 | MP0002933_joint_inflammation | 1.57373022 |
| 44 | MP0002009_preneoplasia | 1.52846990 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.51926586 |
| 46 | MP0004883_abnormal_blood_vessel | 1.44545258 |
| 47 | MP0003690_abnormal_glial_cell | 1.38684544 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.38495180 |
| 49 | MP0005310_abnormal_salivary_gland | 1.21651895 |
| 50 | MP0003448_altered_tumor_morphology | 1.21232096 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.20741644 |
| 52 | MP0000858_altered_metastatic_potential | 1.20318062 |
| 53 | MP0008469_abnormal_protein_level | 1.15980692 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.13832877 |
| 55 | MP0000490_abnormal_crypts_of | 1.12584813 |
| 56 | MP0001545_abnormal_hematopoietic_system | 1.10593143 |
| 57 | MP0005397_hematopoietic_system_phenotyp | 1.10593143 |
| 58 | MP0005167_abnormal_blood-brain_barrier | 1.10303713 |
| 59 | MP0003075_altered_response_to | 1.09473435 |
| 60 | MP0005164_abnormal_response_to | 1.08673471 |
| 61 | MP0008961_abnormal_basal_metabolism | 1.06285503 |
| 62 | MP0004130_abnormal_muscle_cell | 1.01122517 |
| 63 | MP0009278_abnormal_bone_marrow | 1.00992439 |
| 64 | MP0004484_altered_response_of | 0.98300021 |
| 65 | MP0008004_abnormal_stomach_pH | 0.96230986 |
| 66 | MP0004381_abnormal_hair_follicle | 0.96153928 |
| 67 | MP0003045_fibrosis | 0.95277824 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 0.93184527 |
| 69 | MP0001879_abnormal_lymphatic_vessel | 0.92928526 |
| 70 | MP0001533_abnormal_skeleton_physiology | 0.92225231 |
| 71 | MP0002019_abnormal_tumor_incidence | 0.90435501 |
| 72 | MP0000604_amyloidosis | 0.89755592 |
| 73 | MP0010352_gastrointestinal_tract_polyps | 0.87564972 |
| 74 | MP0001851_eye_inflammation | 0.87476689 |
| 75 | MP0003828_pulmonary_edema | 0.84848969 |
| 76 | MP0002132_abnormal_respiratory_system | 0.82184029 |
| 77 | MP0008057_abnormal_DNA_replication | 0.81626541 |
| 78 | MP0009764_decreased_sensitivity_to | 0.80489814 |
| 79 | MP0002136_abnormal_kidney_physiology | 0.79575976 |
| 80 | MP0002332_abnormal_exercise_endurance | 0.79454870 |
| 81 | MP0002998_abnormal_bone_remodeling | 0.78477149 |
| 82 | MP0003091_abnormal_cell_migration | 0.78381428 |
| 83 | MP0005390_skeleton_phenotype | 0.73621327 |
| 84 | MP0009763_increased_sensitivity_to | 0.73331485 |
| 85 | MP0001958_emphysema | 0.70616539 |
| 86 | MP0005174_abnormal_tail_pigmentation | 0.69348469 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68398796 |
| 88 | MP0009115_abnormal_fat_cell | 0.65400747 |
| 89 | MP0005388_respiratory_system_phenotype | 0.64558056 |
| 90 | MP0002133_abnormal_respiratory_system | 0.64558056 |
| 91 | MP0000249_abnormal_blood_vessel | 0.64018467 |
| 92 | MP0009840_abnormal_foam_cell | 0.63537615 |
| 93 | MP0003787_abnormal_imprinting | 0.63455930 |
| 94 | MP0001663_abnormal_digestive_system | 0.63448671 |
| 95 | MP0000609_abnormal_liver_physiology | 0.62834852 |
| 96 | MP0010368_abnormal_lymphatic_system | 0.60834160 |
| 97 | MP0005023_abnormal_wound_healing | 0.59856856 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.57536987 |
| 99 | MP0005670_abnormal_white_adipose | 0.55987413 |
| 100 | MP0005165_increased_susceptibility_to | 0.53253449 |
| 101 | MP0003453_abnormal_keratinocyte_physiol | 0.53071710 |
| 102 | MP0003943_abnormal_hepatobiliary_system | 0.52035955 |
| 103 | MP0006054_spinal_hemorrhage | 0.51860294 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.50533028 |
| 105 | MP0003566_abnormal_cell_adhesion | 0.50396337 |
| 106 | MP0002928_abnormal_bile_duct | 0.49243684 |
| 107 | MP0000477_abnormal_intestine_morphology | 0.48331587 |
| 108 | MP0005451_abnormal_body_composition | 0.47969103 |
| 109 | MP0003279_aneurysm | 0.47526757 |
| 110 | MP0008874_decreased_physiological_sensi | 0.46332237 |
| 111 | MP0001191_abnormal_skin_condition | 0.44981739 |
| 112 | MP0000767_abnormal_smooth_muscle | 0.43911930 |
| 113 | MP0003795_abnormal_bone_structure | 0.43810657 |
| 114 | MP0000343_altered_response_to | 0.43077994 |
| 115 | MP0002277_abnormal_respiratory_mucosa | 0.42229962 |
| 116 | MP0002168_other_aberrant_phenotype | 0.41883913 |
| 117 | MP0003191_abnormal_cellular_cholesterol | 0.41833887 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.40379471 |
| 119 | MP0005166_decreased_susceptibility_to | 0.39350722 |
| 120 | MP0004185_abnormal_adipocyte_glucose | 0.39187357 |
| 121 | MP0003868_abnormal_feces_composition | 0.38650001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.25330276 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.02774825 |
| 3 | Recurrent bronchitis (HP:0002837) | 5.27167394 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.97587862 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 4.89077451 |
| 6 | Agammaglobulinemia (HP:0004432) | 4.80542557 |
| 7 | IgM deficiency (HP:0002850) | 4.80128522 |
| 8 | Abnormality of T cells (HP:0002843) | 4.73673082 |
| 9 | Recurrent viral infections (HP:0004429) | 4.72627423 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 4.64656796 |
| 11 | Chronic otitis media (HP:0000389) | 4.56666418 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.54633830 |
| 13 | Abnormality of the fingertips (HP:0001211) | 4.35511198 |
| 14 | Recurrent fungal infections (HP:0002841) | 4.15955153 |
| 15 | Nasal polyposis (HP:0100582) | 4.11987510 |
| 16 | Inflammation of the large intestine (HP:0002037) | 4.01394029 |
| 17 | Myositis (HP:0100614) | 3.97061684 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.93546819 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.92529664 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.92529664 |
| 21 | Abnormality of the nasal mucosa (HP:0000433) | 3.86118524 |
| 22 | Gastrointestinal inflammation (HP:0004386) | 3.82052124 |
| 23 | Meningitis (HP:0001287) | 3.81906452 |
| 24 | Lymphopenia (HP:0001888) | 3.77697537 |
| 25 | Gastrointestinal stroma tumor (HP:0100723) | 3.73135000 |
| 26 | Colitis (HP:0002583) | 3.71573981 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 3.70190730 |
| 28 | Pustule (HP:0200039) | 3.68753381 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.65248058 |
| 30 | Recurrent sinusitis (HP:0011108) | 3.61937504 |
| 31 | Vasculitis (HP:0002633) | 3.59478041 |
| 32 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.58419915 |
| 33 | Severe combined immunodeficiency (HP:0004430) | 3.51874138 |
| 34 | Encephalitis (HP:0002383) | 3.48031933 |
| 35 | Chronic diarrhea (HP:0002028) | 3.46486594 |
| 36 | IgG deficiency (HP:0004315) | 3.42262763 |
| 37 | Combined immunodeficiency (HP:0005387) | 3.41971386 |
| 38 | Verrucae (HP:0200043) | 3.39952462 |
| 39 | Papilloma (HP:0012740) | 3.39952462 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.39206113 |
| 41 | Stomatitis (HP:0010280) | 3.39018621 |
| 42 | Gingivitis (HP:0000230) | 3.37555760 |
| 43 | Retrobulbar optic neuritis (HP:0100654) | 3.35898308 |
| 44 | Optic neuritis (HP:0100653) | 3.35898308 |
| 45 | Chronic sinusitis (HP:0011109) | 3.15087222 |
| 46 | Autoimmune hemolytic anemia (HP:0001890) | 3.15051139 |
| 47 | IgA deficiency (HP:0002720) | 3.07937151 |
| 48 | Prolonged bleeding time (HP:0003010) | 3.01892708 |
| 49 | Eczematoid dermatitis (HP:0000976) | 3.00569181 |
| 50 | B lymphocytopenia (HP:0010976) | 3.00099756 |
| 51 | Abnormality of B cell number (HP:0010975) | 3.00099756 |
| 52 | Thyroiditis (HP:0100646) | 2.99958768 |
| 53 | Joint swelling (HP:0001386) | 2.94506629 |
| 54 | Bronchitis (HP:0012387) | 2.92999318 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.92553492 |
| 56 | Orchitis (HP:0100796) | 2.89226722 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.87662917 |
| 58 | Increased IgE level (HP:0003212) | 2.85522849 |
| 59 | Eosinophilia (HP:0001880) | 2.85209397 |
| 60 | Emphysema (HP:0002097) | 2.83676341 |
| 61 | Urticaria (HP:0001025) | 2.80728621 |
| 62 | Hemoptysis (HP:0002105) | 2.80088365 |
| 63 | Cellulitis (HP:0100658) | 2.71241377 |
| 64 | Lymphoma (HP:0002665) | 2.69820177 |
| 65 | Mediastinal lymphadenopathy (HP:0100721) | 2.65430666 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.58874745 |
| 67 | Arterial thrombosis (HP:0004420) | 2.57623876 |
| 68 | Granulocytopenia (HP:0001913) | 2.54403533 |
| 69 | Amyloidosis (HP:0011034) | 2.53940991 |
| 70 | Leukocytosis (HP:0001974) | 2.52441743 |
| 71 | Epistaxis (HP:0000421) | 2.51641192 |
| 72 | Recurrent skin infections (HP:0001581) | 2.50679886 |
| 73 | Keratoconjunctivitis sicca (HP:0001097) | 2.48556155 |
| 74 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.48549211 |
| 75 | Abnormal platelet volume (HP:0011876) | 2.48184696 |
| 76 | Peritonitis (HP:0002586) | 2.47423872 |
| 77 | Pulmonary embolism (HP:0002204) | 2.47241818 |
| 78 | Systemic lupus erythematosus (HP:0002725) | 2.43589656 |
| 79 | Thrombocytosis (HP:0001894) | 2.43475655 |
| 80 | Basal cell carcinoma (HP:0002671) | 2.42885324 |
| 81 | Recurrent otitis media (HP:0000403) | 2.41992120 |
| 82 | Chest pain (HP:0100749) | 2.39721433 |
| 83 | Osteomyelitis (HP:0002754) | 2.36531800 |
| 84 | Polycythemia (HP:0001901) | 2.36448662 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 2.30502714 |
| 86 | Obstructive lung disease (HP:0006536) | 2.30502714 |
| 87 | Episodic fever (HP:0001954) | 2.29661989 |
| 88 | Purpura (HP:0000979) | 2.29388090 |
| 89 | Anorexia (HP:0002039) | 2.28737121 |
| 90 | Hypochromic anemia (HP:0001931) | 2.27722110 |
| 91 | Keratoconjunctivitis (HP:0001096) | 2.26993939 |
| 92 | Gangrene (HP:0100758) | 2.22544527 |
| 93 | Restrictive lung disease (HP:0002091) | 2.21845774 |
| 94 | Abnormality of the pleura (HP:0002103) | 2.20955791 |
| 95 | Hypochromic microcytic anemia (HP:0004840) | 2.20196050 |
| 96 | Ureteral stenosis (HP:0000071) | 2.20122570 |
| 97 | Gingival bleeding (HP:0000225) | 2.17003922 |
| 98 | Petechiae (HP:0000967) | 2.14804871 |
| 99 | Abnormality of the endocardium (HP:0004306) | 2.11691031 |
| 100 | Abnormality of glycolipid metabolism (HP:0010969) | 2.08716819 |
| 101 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.08716819 |
| 102 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.08716819 |
| 103 | Hemiplegia (HP:0002301) | 2.08145057 |
| 104 | Gastrointestinal infarctions (HP:0005244) | 2.07949650 |
| 105 | Recurrent bacterial skin infections (HP:0005406) | 2.06975818 |
| 106 | Hepatitis (HP:0012115) | 2.05494451 |
| 107 | Vertigo (HP:0002321) | 2.05391636 |
| 108 | Glomerulopathy (HP:0100820) | 2.03791500 |
| 109 | Abnormality of the peritoneum (HP:0002585) | 2.02587580 |
| 110 | Ureteral obstruction (HP:0006000) | 2.01719087 |
| 111 | Viral hepatitis (HP:0006562) | 2.01141468 |
| 112 | Sepsis (HP:0100806) | 2.00807019 |
| 113 | Increased IgM level (HP:0003496) | 1.99216909 |
| 114 | Increased mean platelet volume (HP:0011877) | 1.96190017 |
| 115 | Loss of speech (HP:0002371) | 1.95568799 |
| 116 | Skin ulcer (HP:0200042) | 1.94217097 |
| 117 | Aortic aneurysm (HP:0004942) | 1.93781561 |
| 118 | Increased density of long bones (HP:0006392) | 1.93189097 |
| 119 | Acne (HP:0001061) | 1.93059827 |
| 120 | Abnormality of the prostate (HP:0008775) | 1.92972686 |
| 121 | Leukopenia (HP:0001882) | 1.91238726 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.91221373 |
| 123 | Arthralgia (HP:0002829) | 1.91034982 |
| 124 | Hematochezia (HP:0002573) | 1.90979533 |
| 125 | Slow saccadic eye movements (HP:0000514) | 1.89759266 |
| 126 | Thrombophlebitis (HP:0004418) | 1.89023644 |
| 127 | Difficulty running (HP:0009046) | 1.86549238 |
| 128 | Polyneuropathy (HP:0001271) | 1.86224983 |
| 129 | Periodontitis (HP:0000704) | 1.85941345 |
| 130 | Hypoplasia of the thymus (HP:0000778) | 1.85466710 |
| 131 | Microcytic anemia (HP:0001935) | 1.82034777 |
| 132 | Bronchiectasis (HP:0002110) | 1.80748816 |
| 133 | Interstitial pulmonary disease (HP:0006530) | 1.79113197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 6.03803544 |
| 2 | TXK | 5.24867535 |
| 3 | RIPK4 | 4.04684901 |
| 4 | JAK3 | 3.12815249 |
| 5 | ITK | 2.91572279 |
| 6 | FGFR4 | 2.80487021 |
| 7 | STK10 | 2.68712475 |
| 8 | TYK2 | 2.53791905 |
| 9 | JAK1 | 2.49306842 |
| 10 | IKBKE | 2.47537557 |
| 11 | GRK6 | 2.42638986 |
| 12 | PRPF4B | 2.42206876 |
| 13 | MAP3K14 | 2.38693726 |
| 14 | ZAP70 | 2.27848943 |
| 15 | FGFR3 | 2.12677428 |
| 16 | MAP3K13 | 2.11130734 |
| 17 | TEC | 1.84972945 |
| 18 | NLK | 1.82438674 |
| 19 | TGFBR2 | 1.75748909 |
| 20 | LCK | 1.71848623 |
| 21 | BTK | 1.67112731 |
| 22 | MARK3 | 1.66587259 |
| 23 | FGR | 1.61940198 |
| 24 | CSK | 1.61801157 |
| 25 | SYK | 1.60310668 |
| 26 | MAP3K10 | 1.53036209 |
| 27 | EEF2K | 1.48460472 |
| 28 | SIK2 | 1.44245848 |
| 29 | MAP3K3 | 1.39073390 |
| 30 | TBK1 | 1.37268093 |
| 31 | HCK | 1.33967166 |
| 32 | PRKCQ | 1.33459454 |
| 33 | KIT | 1.30129903 |
| 34 | LRRK2 | 1.27338187 |
| 35 | PRKCH | 1.24581079 |
| 36 | IKBKB | 1.22381259 |
| 37 | KDR | 1.21156014 |
| 38 | IRAK4 | 1.16318512 |
| 39 | PIM1 | 1.15494697 |
| 40 | TAOK1 | 1.15204455 |
| 41 | MAP3K11 | 1.12967024 |
| 42 | MST4 | 1.11497827 |
| 43 | BLK | 1.10562441 |
| 44 | CDK12 | 1.09563883 |
| 45 | MAP3K1 | 1.09232208 |
| 46 | CSF1R | 1.08302299 |
| 47 | YES1 | 1.05966034 |
| 48 | SIK3 | 1.04795987 |
| 49 | IRAK3 | 1.00642516 |
| 50 | MAP3K7 | 0.96730027 |
| 51 | KSR2 | 0.95505940 |
| 52 | FES | 0.93661222 |
| 53 | CAMKK2 | 0.93055348 |
| 54 | JAK2 | 0.91607005 |
| 55 | CHUK | 0.89136596 |
| 56 | PKN2 | 0.88273010 |
| 57 | TNK2 | 0.87180506 |
| 58 | LYN | 0.86722532 |
| 59 | TTN | 0.85174040 |
| 60 | MAP3K6 | 0.84735481 |
| 61 | RPS6KA4 | 0.83104926 |
| 62 | CDC42BPA | 0.82042303 |
| 63 | TIE1 | 0.79575924 |
| 64 | PRKD2 | 0.78264075 |
| 65 | CLK1 | 0.76408216 |
| 66 | PDPK1 | 0.76289903 |
| 67 | MAPK7 | 0.75081113 |
| 68 | EPHB1 | 0.75011686 |
| 69 | EPHA3 | 0.71385695 |
| 70 | STK24 | 0.69095851 |
| 71 | RIPK1 | 0.68965643 |
| 72 | BMPR2 | 0.68620919 |
| 73 | TGFBR1 | 0.68275636 |
| 74 | BRD4 | 0.68010151 |
| 75 | PIK3CG | 0.67922560 |
| 76 | MATK | 0.66146685 |
| 77 | MAPK12 | 0.64896801 |
| 78 | MAP2K3 | 0.64663260 |
| 79 | CDK4 | 0.61271428 |
| 80 | HIPK2 | 0.60461329 |
| 81 | PTK2B | 0.59882226 |
| 82 | PDK1 | 0.58255097 |
| 83 | NUAK1 | 0.57359126 |
| 84 | FGFR2 | 0.57036240 |
| 85 | CAMKK1 | 0.55611037 |
| 86 | MAP3K2 | 0.55034076 |
| 87 | PDGFRB | 0.54351224 |
| 88 | FLT3 | 0.53258697 |
| 89 | TRPM7 | 0.51588725 |
| 90 | SIK1 | 0.50527539 |
| 91 | MARK2 | 0.50488935 |
| 92 | MELK | 0.48684883 |
| 93 | SGK3 | 0.48402482 |
| 94 | DYRK1B | 0.47056148 |
| 95 | GRK1 | 0.46018865 |
| 96 | DMPK | 0.45942580 |
| 97 | RET | 0.45473051 |
| 98 | CDK9 | 0.45176804 |
| 99 | TAOK3 | 0.44342271 |
| 100 | ERN1 | 0.42870042 |
| 101 | TAOK2 | 0.42776850 |
| 102 | NME2 | 0.42677659 |
| 103 | PTK6 | 0.41016758 |
| 104 | MAP3K5 | 0.39991627 |
| 105 | INSR | 0.39983441 |
| 106 | TYRO3 | 0.39934542 |
| 107 | STK4 | 0.38889724 |
| 108 | RPS6KL1 | 0.37220915 |
| 109 | RPS6KC1 | 0.37220915 |
| 110 | IGF1R | 0.36981824 |
| 111 | ALK | 0.36655234 |
| 112 | SMG1 | 0.36377715 |
| 113 | FER | 0.35110958 |
| 114 | CDK6 | 0.34531804 |
| 115 | STK38 | 0.33594236 |
| 116 | MAPK11 | 0.32945476 |
| 117 | MAPK4 | 0.32488414 |
| 118 | IRAK1 | 0.32376637 |
| 119 | RAF1 | 0.32049110 |
| 120 | ABL1 | 0.31384478 |
| 121 | PRKAA2 | 0.31212334 |
| 122 | CAMK1G | 0.30097481 |
| 123 | TRIB3 | 0.29429829 |
| 124 | FYN | 0.28809108 |
| 125 | SGK2 | 0.26900364 |
| 126 | STK11 | 0.26210649 |
| 127 | MAPK3 | 0.25248449 |
| 128 | PRKD1 | 0.24377819 |
| 129 | GRK7 | 0.22552548 |
| 130 | NEK9 | 0.22131940 |
| 131 | EGFR | 0.19670761 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.52540295 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.37132243 |
| 3 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.07535277 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.88032623 |
| 5 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.87946443 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.85453241 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.81788115 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.80046637 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.65253014 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.60747420 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.48889585 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.32001348 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.19694614 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.07418731 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.94578735 |
| 16 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.89124412 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83149511 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.79371592 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.61459252 |
| 20 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.55745491 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50895253 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.41942689 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.40772503 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.39281258 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.38627777 |
| 26 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.34475117 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33173360 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32656686 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32534444 |
| 30 | Influenza A_Homo sapiens_hsa05164 | 1.27373751 |
| 31 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.27223015 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.25715815 |
| 33 | Platelet activation_Homo sapiens_hsa04611 | 1.24971303 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.24629311 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.23612309 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.22635673 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.12231003 |
| 38 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.06962622 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.06641194 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.05761359 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.04670451 |
| 42 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.04292655 |
| 43 | Malaria_Homo sapiens_hsa05144 | 0.99574423 |
| 44 | HTLV-I infection_Homo sapiens_hsa05166 | 0.99056007 |
| 45 | Hepatitis C_Homo sapiens_hsa05160 | 0.96498109 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.96455145 |
| 47 | Shigellosis_Homo sapiens_hsa05131 | 0.93284326 |
| 48 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87671865 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.84939688 |
| 50 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.84812408 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83500378 |
| 52 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.80683890 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78237481 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.78086931 |
| 55 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76908268 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.73204386 |
| 57 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70312031 |
| 58 | Asthma_Homo sapiens_hsa05310 | 0.69336656 |
| 59 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.65700927 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65644722 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65437487 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65174946 |
| 63 | Lysine degradation_Homo sapiens_hsa00310 | 0.64817593 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.64718404 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64603897 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63946882 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61365063 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.60924227 |
| 69 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60037168 |
| 70 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59683820 |
| 71 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.59544154 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.58700777 |
| 73 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.58490694 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.56601969 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.56286578 |
| 76 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.55401194 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55019917 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.53923139 |
| 79 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.52667571 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50912525 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49403927 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.47506961 |
| 83 | Salmonella infection_Homo sapiens_hsa05132 | 0.47485065 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.47482240 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46837889 |
| 86 | Prostate cancer_Homo sapiens_hsa05215 | 0.45802972 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43705759 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42345996 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39467019 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39399293 |
| 91 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38816472 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.38051249 |
| 93 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.37425913 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37210333 |
| 95 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37171619 |
| 96 | Ribosome_Homo sapiens_hsa03010 | 0.36384982 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.35553385 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.35429856 |
| 99 | Long-term potentiation_Homo sapiens_hsa04720 | 0.34549198 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34466385 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.34380515 |
| 102 | Pathways in cancer_Homo sapiens_hsa05200 | 0.33918828 |
| 103 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.33856043 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.33416052 |
| 105 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33412309 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.32023302 |
| 107 | Focal adhesion_Homo sapiens_hsa04510 | 0.31826809 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.30489074 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.30099807 |
| 110 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28000465 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.25123745 |
| 112 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24793816 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.23371944 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.22226930 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20744774 |

